Literature DB >> 9839301

Oxidative damage to DNA in plaques of MS brains.

O Vladimirova1, J O'Connor, A Cahill, H Alder, C Butunoi, B Kalman.   

Abstract

A major cause of clinical disability in multiple sclerosis (MS) is related to a degenerative process in the central nervous system (CNS) which ultimately develops from a potentially reversible inflammation and demyelination. The mechanism of this degenerative process within MS lesions is not completely understood. We hypothesize that oxidative damage to DNA secondary to inflammation may contribute to irreversible tissue alterations in a plaque. To test this assumption, we determined the level of a DNA oxidative marker, 8-hydroxy-deoxy-guanosine (8-OH-dG) in the normal appearing white matter (NAWM), plaque and cortical regions of cerebella from MS patients who suffered from severe cerebellar symptoms during the course of the disease, and in NAWM and cortical regions of cerebella from non-neurological controls. We found a significant increase in DNA oxidation within plaques compared to NAWM specimens in MS cerebella. A tendency for increase of oxidative markers in normal appearing cortical tissues located in the proximity of MS plaques was also observed when compared to those in control cortical specimens. Oxidative damage to DNA in MS lesions, and in neuron rich areas located in the proximity of these lesions is likely related to the release of reactive oxygen species (ROS) and nitric oxide (NO) during inflammation in the brain. This biochemical impairment of DNA and of other macromolecules may contribute to the development of severe clinical disability through the induction of degenerative changes within and outside of plaques in MS brains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839301     DOI: 10.1177/135245859800400503

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  30 in total

1.  Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli.

Authors:  Jaime Imitola; Manuel Comabella; Anil K Chandraker; Fernando Dangond; Mohamed H Sayegh; Evan Y Snyder; Samia J Khoury
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 2.  Role of mitochondria in multiple sclerosis.

Authors:  Bernadette Kalman
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

3.  Variations in mitochondrial DNA copy numbers in MS brains.

Authors:  Andrei Blokhin; Tamara Vyshkina; Samuel Komoly; Bernadette Kalman
Journal:  J Mol Neurosci       Date:  2008-06-20       Impact factor: 3.444

4.  Variation within DNA repair pathway genes and risk of multiple sclerosis.

Authors:  Farren B S Briggs; Benjamin A Goldstein; Jacob L McCauley; Rebecca L Zuvich; Philip L De Jager; John D Rioux; Adrian J Ivinson; Alastair Compston; David A Hafler; Stephen L Hauser; Jorge R Oksenberg; Stephen J Sawcer; Margaret A Pericak-Vance; Jonathan L Haines; Lisa F Barcellos
Journal:  Am J Epidemiol       Date:  2010-06-03       Impact factor: 4.897

Review 5.  DNA damage in the oligodendrocyte lineage and its role in brain aging.

Authors:  Kai-Hei Tse; Karl Herrup
Journal:  Mech Ageing Dev       Date:  2016-05-26       Impact factor: 5.432

Review 6.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

7.  Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Che-Lin Hu; Mara Nydes; Kara L Shanley; Itzy E Morales Pantoja; Tamara A Howard; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2018-12-03       Impact factor: 5.372

8.  Lack of mitochondrial DNA deletions in lesions of multiple sclerosis.

Authors:  Andrei Blokhin; Tamara Vyshkina; Samuel Komoly; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2008       Impact factor: 3.843

9.  Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress.

Authors:  Jingdong Qin; Rajendra Goswami; Sylvia Dawson; Glyn Dawson
Journal:  J Neurosci Res       Date:  2008-08-15       Impact factor: 4.164

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.